Your browser doesn't support javascript.
loading
Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria.
Hokelekli, Fatma Ozlem; Duffy, Joseph R; Clark, Heather M; Utianski, Rene L; Botha, Hugo; Ali, Farwa; Stierwalt, Julie A; Machulda, Mary M; Reichard, R Ross; Dickson, Dennis W; Whitwell, Jennifer L; Josephs, Keith A.
Afiliação
  • Hokelekli FO; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Duffy JR; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Clark HM; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Utianski RL; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Botha H; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ali F; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Stierwalt JA; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Reichard RR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dickson DW; Department of Neuroscience (Neuropathology), Mayo Clinic, Jacksonville, Florida, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Mov Disord ; 37(1): 213-218, 2022 01.
Article em En | MEDLINE | ID: mdl-34632629
BACKGROUND: Progressive supranuclear palsy (PSP) may present as a speech/language disorder (PSP-SL). OBJECTIVE: We assessed pathological correlates of patients with PSP-SL who retained the suggestive of PSP-SL (s.o. PSP-SL) diagnosis versus those who progressed to possible/probable (poss./prob.) PSP. METHODS: Thirty-four prospectively recruited patient with s.o. PSP-SL completed comprehensive speech/language and neurological assessments longitudinally, died, and underwent autopsy. RESULTS: Twelve patients (35%) evolved to poss./prob PSP, while 22 (65%) remained as s.o. PSP-SL. Pathological diagnoses differed across the groups (P = 0.025). Patients with s.o. PSP-SL had four different neuropathologies (corticobasal degeneration [59%], PSP [13%], Pick's disease [14%], and frontotemporal lobar degeneration with TDP-43 [14%]), while all patients with poss./prob. PSP had a 4R-tauopathy (PSP [67%] and corticobasal degeneration [33%]). Development of poss./prob. PSP increased the chance of having PSP pathology by 2.38 times. CONCLUSIONS: PSP-SL is associated with heterogenous pathologies. Evolution of PSP-SL into poss./prob. PSP is more predictive of underlying PSP pathology than s.o. PSP-SL. © 2021 International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Tauopatias / Transtornos da Linguagem Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Tauopatias / Transtornos da Linguagem Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article